Patents by Inventor Albertus Wernerus Wognum

Albertus Wernerus Wognum has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MEDIA AND METHODS FOR DIFFERENTIATING NATURAL KILLER CELLS
    Publication number: 20220056412
    Abstract: Media and methods for differentiating NK progenitor cells into NK cells are disclosed. The NK differentiation media comprises a pyrimidoindole compound such as UM171 or UM729.
    Type: Application
    Filed: December 20, 2019
    Publication date: February 24, 2022
    Inventors: Nooshin Tabatabaei-Zavareh, Albertus Wernerus Wognum
  • Tetrameric antibody complexes for blocking non-specific labeling of antigens
    Patent number: 7387897
    Abstract: A method for preventing or inhibiting non-specific binding reactions between a detection reagent and an antigen in an immunological assay is described. The method involves using tetrameric antibody complexes that can bind to the antigen and are comprised of two monoclonal antibodies of a first animal species linked to two monoclonal antibodies of a second animal species that can bind the antibodies of the first animal species. Preferably, the antigen is an Fc Receptor and the method reduces the binding of a detection antibody with Fc receptors present on the surface of many cells.
    Type: Grant
    Filed: September 22, 2006
    Date of Patent: June 17, 2008
    Assignee: StemCell Technologies Inc.
    Inventors: Albertus Wernerus Wognum, Peter Michael Lansdorp
  • Tetrameric antibody complexes for blocking non-specific labeling of antigens
    Patent number: 7135340
    Abstract: A method for preventing or inhibiting non-specific binding reactions between a detection reagent and an antigen in an immunological assay is described. The method involves using tetrameric antibody complexes that can bind to the antigen and are comprised of two monoclonal antibodies of a first animal species linked to two monoclonal antibodies of a second animal species that can bind the antibodies of the first animal species. Preferably, the antigen is an Fc Receptor and the method reduces the binding of a detection antibody with Fc receptors present on the surface of many cells.
    Type: Grant
    Filed: November 7, 2002
    Date of Patent: November 14, 2006
    Assignee: Stemcell Technologies Inc.
    Inventors: Albertus Wernerus Wognum, Peter Michael Lansdorp
  • Tetrameric antibody complexes for blocking non-specific labeling of antigens
    Publication number: 20030119071
    Abstract: A method for preventing or inhibiting non-specific binding reactions between a detection reagent and an antigen in an immunological assay is described. The method involves using tetrameric antibody complexes that can bind to the antigen and are comprised of two monoclonal antibodies of a first animal species linked to two monoclonal antibodies of a second animal species that can bind the antibodies of the first animal species. Preferably, the antigen is an Fc Receptor and the method reduces the binding of a detection antibody with Fc receptors present on the surface of many cells.
    Type: Application
    Filed: November 7, 2002
    Publication date: June 26, 2003
    Inventors: Albertus Wernerus Wognum, Peter Michael Lansdorp